Tuberous sclerosis is another AD “tumor syndrome,” caused by pathogenic variants in the TSC1 or TSC2 tumor suppressor genes, tuberin and hamartin, that inhibit the mammalian target of rapamycin (mTOR) pathway. This evidence concerns the gene TSC1 and neoplasm.